rfhg_212610.1

Basic information about the TSS

---

TSS ID: rfhg_212610.1 Species: human Chr: chr19		Start: 41861111 End: 41861121 Strand: +
Source datasets	PRJNA401781
Protocol	oligo_capping
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3063124,EH38E1955056)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000598399.1:-333 GeneID: 6223 HGNC/MGI_ID: HGNC:10402 UniProt_ID: M0R2L9 Nearer transcript ids and distances: AB528300:-336 EU176636:-336 DQ891823:-336 BC007615:-336 view more...

Gene_name: ribosomal protein S19 Gene_symbol: RPS19 Gene_synonyms: DBA S19 eS19 Gene_source: HGNC:10402

TATA-Box annotation

---

Distance to TSS:	712
Nearest PromoterID:	NM_001321483
Entrez ID:	6223
Nearest Unigene:	Hs.438429
Nearest Refseq:	NM_001022
Nearest Ensembl:	ENSG00000105372
Gene Name:	ribosomal protein S19
Gene Alias:	DBA|DBA1|S19|eS19
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.727273
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPS19 p2@RPS19 p3@RPS19 p4@RPS19 p5@RPS19
Sample		p1@RPS19	p2@RPS19	p3@RPS19	p4@RPS19	p5@RPS19
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	67.40	50.65	6.62	16.36	3.31
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	82.14	50.17	6.68	10.52	5.87
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	81.21	58.06	5.98	12.35	4.82
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	68.61	44.28	5.41	10.81	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	70.86	45.22	6.97	11.70	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	70.74	47.48	4.65	12.60	3.88
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	104.15	58.17	5.23	18.08	4.79
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.33	62.25	4.60	15.02	3.88
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	80.36	52.36	6.84	16.24	4.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	91.58	25.50	5.22	9.27	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.91	28.70	6.47	12.13	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	68.71	29.27	4.07	7.72	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.69	14.51	2.42	1.61	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.67	14.58	1.50	1.80	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.69	11.42	1.54	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	25.90	12.57	2.77	2.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.96	12.45	1.97	2.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.42	11.81	0.84	3.80	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.66	18.13	1.60	3.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.46	20.01	2.56	2.41	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.42	17.78	1.87	2.54	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	31.94	16.23	1.21	1.73	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.70	12.15	2.59	1.55	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.36	15.05	2.18	1.46	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.51	13.93	2.58	1.55	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.03	17.09	3.17	3.80	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	15.93	0.00	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.01	22.63	2.83	3.06	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	33.92	21.64	2.10	2.91	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.69	20.27	2.90	2.71	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.84	23.66	1.67	3.35	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.35	15.24	1.17	2.34	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.44	17.52	2.11	2.74	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.05	20.45	2.31	4.62	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.41	21.88	1.68	2.80	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.57	21.27	1.34	2.49	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.14	19.21	2.45	1.84	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.18	19.14	2.22	2.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.92	23.50	4.32	2.97	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.69	16.80	3.36	2.16	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	27.05	12.94	3.76	1.88	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	31.77	16.54	2.20	4.10	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.10	25.94	3.37	3.16	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	23.78	21.15	2.27	3.50	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.72	23.09	5.42	3.41	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	37.46	26.29	3.02	2.79	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	27.35	24.23	2.40	3.60	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	38.15	27.12	4.47	2.98	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.22	32.08	3.35	1.91	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.73	30.33	3.03	3.24	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.32	29.92	3.07	3.07	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.58	30.69	2.45	3.11	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	41.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.65	19.52	2.84	1.77	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.53	22.20	1.99	1.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	40.27	12.58	2.52	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	31.69	18.37	2.76	4.13	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.88	25.93	5.83	1.30	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.16	20.23	4.18	2.89	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.15	24.52	3.46	4.09	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	24.68	26.09	2.82	0.71	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.43	14.02	4.49	1.68	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	7.96	3.98	5.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.71	18.35	1.70	2.04	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.55	34.12	1.95	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	10.29	2.48	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.96	14.14	1.95	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.34	12.40	0.99	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	9.38	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	9.94	0.99	0.33	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.40	12.37	1.55	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.59	9.48	0.31	0.31	1.53
Adipocyte - breast, donor1	11376-118A8	47.67	17.26	3.80	1.11	0.48
Adipocyte - breast, donor2	11327-117E4	28.24	16.20	4.65	0.64	2.89
Adipocyte - omental, donor1	11473-119C6	37.79	11.07	2.67	0.64	0.64
Adipocyte - omental, donor2	11474-119C7	56.81	31.39	4.48	2.24	2.99
Adipocyte - omental, donor3	11475-119C8	67.99	21.10	8.04	1.34	4.69
Adipocyte - perirenal, donor1	11476-119C9	109.10	26.16	8.93	1.28	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	32.99	12.09	3.30	0.00	5.50
Adipocyte - subcutaneous, donor2	11336-117F4	53.74	23.03	3.61	1.35	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	58.56	10.60	4.34	0.35	5.21
Adipocyte differentiation, day04, donor1	13019-139D4	34.23	12.71	1.76	0.20	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	23.42	16.99	2.57	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	20.35	3.62	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	34.68	6.47	2.35	2.35	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	39.09	15.68	2.98	0.00	5.47
Adipocyte differentiation, day08, donor2	13023-139D8	34.86	16.46	1.61	0.65	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	33.06	12.26	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	55.09	11.69	3.34	0.56	3.34
Adipocyte differentiation, day12, donor1	13021-139D6	24.12	12.48	6.65	0.00	5.82
Adipocyte differentiation, day12, donor2	13024-139D9	21.60	14.07	3.01	0.25	2.01
Adipocyte differentiation, day12, donor3	13027-139E3	24.22	14.40	6.22	0.33	2.95
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	17.05	2.74	0.00	2.44
Alveolar Epithelial Cells, donor1	11510-119G7	93.92	59.89	3.76	2.43	3.31
Alveolar Epithelial Cells, donor2	11590-120G6	93.23	87.49	4.66	1.79	8.61
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	25.16	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	62.43	24.11	2.70	0.90	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	68.61	20.08	0.00	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	48.49	30.00	3.70	1.64	0.62
Anulus Pulposus Cell, donor1	11248-116E6	88.22	22.08	2.17	0.69	0.34
Anulus Pulposus Cell, donor2	11463-119B5	67.59	32.33	1.96	0.49	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	92.55	62.45	8.54	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	91.60	69.90	6.51	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	59.93	70.63	8.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	75.93	53.81	7.47	0.60	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	84.73	86.00	6.32	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	77.23	70.63	7.92	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	90.64	72.45	9.10	2.60	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	103.40	78.16	10.19	3.40	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	65.92	55.82	10.10	1.78	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	95.29	78.72	9.04	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	106.67	66.04	11.61	2.18	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	70.21	65.20	2.51	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	70.84	41.18	4.94	1.32	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	135.12	75.06	13.65	4.09	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	79.77	45.24	9.05	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	85.73	73.94	5.36	1.61	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	74.25	55.36	7.75	2.08	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	74.31	51.59	6.95	1.34	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	105.35	74.13	12.68	0.98	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	66.84	53.08	9.29	1.00	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	61.24	64.84	7.20	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	113.28	53.10	10.62	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	61.92	44.77	5.49	0.86	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	71.31	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	101.45	78.15	8.74	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	83.10	54.26	8.73	1.14	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	62.99	76.32	16.96	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	95.77	81.51	10.26	0.00	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	82.52	48.74	8.55	1.50	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	69.17	53.42	4.65	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	94.78	68.50	9.38	0.00	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	75.24	50.16	8.36	1.61	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	80.62	69.20	9.99	0.00	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	93.01	84.82	11.11	2.92	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	73.76	53.89	6.62	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	68.90	43.96	7.13	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	108.32	80.35	9.66	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	75.90	44.32	8.91	1.78	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	67.35	57.82	13.34	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	87.17	59.12	8.63	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	73.88	49.75	8.89	1.48	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	71.92	53.36	8.99	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	100.14	52.91	6.61	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	65.61	46.11	6.10	1.53	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	57.91	44.01	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	166.89	67.60	10.56	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	72.47	53.60	8.79	0.64	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	72.20	52.34	8.42	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	96.95	66.34	13.85	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	71.03	54.71	8.74	1.15	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	28.05	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	90.76	66.35	7.88	0.25	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	87.32	54.09	10.53	1.65	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	59.06	55.69	10.71	2.14	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	96.08	61.19	11.47	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	67.41	47.90	7.76	0.44	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	57.98	44.25	16.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	104.68	70.90	9.97	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	69.91	53.22	6.88	1.06	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	66.15	62.15	4.36	2.18	1.45
Astrocyte - cerebellum, donor1	11500-119F6	96.17	32.30	2.21	3.56	1.35
Astrocyte - cerebellum, donor2	11580-120F5	63.16	52.89	4.79	3.08	2.74
Astrocyte - cerebellum, donor3	11661-122F5	73.20	19.09	1.89	1.68	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	102.48	26.14	1.05	1.74	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	69.40	35.91	3.07	2.91	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	42.66	17.75	0.75	2.54	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	70.99	43.24	5.28	3.67	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	59.38	38.09	5.39	5.76	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.56	37.55	4.78	3.76	0.91
Basophils, donor1	12241-129G9	41.32	1.83	0.00	0.52	0.00
Basophils, donor2	12242-129H1	66.39	5.77	0.36	0.00	0.36
Basophils, donor3	12243-129H2	35.87	5.59	0.59	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	113.84	27.17	5.82	0.43	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	86.41	48.00	11.89	2.29	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	57.39	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	89.75	63.39	36.40	1.26	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	58.64	40.34	29.32	1.87	6.45
Bronchial Epithelial Cell, donor6	11461-119B3	75.54	40.07	15.20	0.00	4.15
Bronchial Epithelial Cell, donor7	11769-123I5	60.64	22.49	6.84	0.36	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	152.62	39.57	3.09	1.96	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	152.32	49.38	3.96	2.33	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	161.81	43.81	4.16	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	24.80	4.51	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	35.26	4.08	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	30.08	4.17	0.66	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	36.51	2.26	0.85	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.09	5.69	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	18.74	2.30	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	26.16	2.02	0.29	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	21.42	2.72	0.60	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	24.87	1.18	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	1.67	0.00	1.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.08	2.21	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.28	1.98	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.26	2.15	0.00	0.59	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	26.00	1.60	0.18	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.56	3.26	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	25.29	0.70	0.00	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	27.99	2.64	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	2.22	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.14	1.78	0.00	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.34	2.59	0.40	1.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	43.51	2.29	0.62	0.62	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.43	1.83	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	35.74	0.68	0.23	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	30.12	2.18	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	20.98	2.42	0.00	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.74	2.09	0.35	1.05	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.93	2.95	0.00	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.01	2.20	0.18	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.07	2.11	0.00	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	30.27	1.32	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.05	1.22	0.52	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.84	4.46	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.80	3.66	0.22	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	29.07	1.64	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	33.61	1.85	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.71	2.55	0.00	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	75.20	7.85	3.05	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	81.77	9.70	2.31	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	78.41	11.91	2.38	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	34.88	7.01	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	39.12	5.94	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	23.19	3.57	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	176.33	12.76	3.32	0.77	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	127.13	5.71	2.42	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	130.12	11.58	2.74	0.21	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	217.46	32.52	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	174.92	19.66	2.71	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	188.48	31.07	1.04	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	206.82	22.39	2.67	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	200.49	28.41	1.07	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	173.38	26.67	2.11	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	188.25	17.26	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	268.93	25.05	7.91	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	98.63	8.22	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	90.68	9.43	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	83.80	7.57	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	82.02	33.54	5.66	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	91.48	35.16	6.79	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	182.74	19.08	4.02	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	191.01	19.10	2.25	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	155.19	36.82	1.88	2.25	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	150.17	39.69	1.35	2.03	0.23
CD4+ T Cells, donor1	11225-116C1	149.25	8.21	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	182.48	20.21	1.22	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	87.84	7.93	0.61	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	132.72	34.71	6.13	1.02	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	145.76	39.30	4.94	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	188.00	39.38	5.75	1.44	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	198.17	21.81	2.84	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	287.25	23.18	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	197.77	23.07	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	76.16	18.93	5.49	1.16	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	137.77	47.62	5.76	0.85	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	118.16	42.88	5.80	0.97	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	139.87	19.73	3.14	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	141.15	20.61	3.14	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	99.44	17.60	0.00	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	156.01	30.36	6.32	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	144.19	44.05	7.48	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	171.74	58.81	10.02	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	157.72	14.96	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	195.09	16.08	1.07	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	134.49	8.97	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	119.60	39.13	7.60	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	75.38	32.93	3.25	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	71.24	23.54	5.67	0.84	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	161.29	17.70	3.03	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	158.57	22.96	0.87	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	105.90	12.64	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	244.47	26.23	1.98	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	300.96	32.31	3.69	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	300.10	33.50	1.40	8.37	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	200.22	18.55	2.49	2.77	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	210.30	14.48	1.47	1.23	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	246.40	30.80	3.08	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	167.60	15.76	0.72	2.15	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	211.90	22.16	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	119.17	9.82	1.31	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	122.77	9.39	1.88	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	101.25	11.36	1.51	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	39.46	49.78	7.57	2.98	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	35.47	43.38	5.75	2.88	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	55.27	36.66	7.11	3.01	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	51.34	58.54	4.50	3.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	29.52	31.44	7.20	1.68	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.75	45.93	9.10	2.96	2.05
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	45.63	54.10	10.43	4.56	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	40.27	53.69	8.69	3.42	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.18	51.59	8.68	1.64	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.13	59.47	10.57	5.13	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	50.55	60.72	9.30	1.74	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	54.62	74.87	11.19	3.73	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.20	28.89	10.94	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	38.26	35.07	9.11	1.37	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.83	15.66	7.46	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	47.54	52.94	7.56	2.52	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	36.83	44.02	9.49	1.44	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.96	37.95	7.31	0.94	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	49.44	52.61	12.04	2.85	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	45.21	50.44	12.30	1.54	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	47.77	46.48	8.66	3.21	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	53.93	57.37	9.18	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	38.62	56.75	9.06	2.36	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	39.33	54.46	8.32	4.54	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	24.09	8.03	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.17	16.79	11.89	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	32.06	24.04	11.02	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	14.62	21.93	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	53.36	37.06	2.47	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	78.50	20.10	1.58	1.16	1.89
Chondrocyte - de diff, donor1	11261-116G1	57.55	13.52	1.39	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	45.13	23.10	5.33	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	41.64	11.26	1.71	0.23	0.23
Chondrocyte - re diff, donor2	11339-117F7	22.38	16.11	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	35.59	12.54	2.43	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	65.18	25.59	3.10	2.07	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	65.84	32.92	3.42	1.92	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	36.02	21.59	2.04	2.30	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.28	4.03	1.93	1.38	0.09
Corneal Epithelial Cells, donor1	11526-119I5	75.75	36.89	9.88	0.00	1.54
Corneal Epithelial Cells, donor2	11606-120I4	108.07	54.60	5.69	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	63.14	36.81	8.95	0.77	4.60
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.54	7.43	1.49	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.01	11.67	2.84	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.20	8.53	1.84	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	128.46	9.22	1.02	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	132.53	13.06	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	115.66	14.03	0.00	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	47.53	38.36	6.00	0.83	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	44.59	63.96	5.28	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	65.89	30.54	2.83	2.55	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	42.07	5.90	1.18	4.72
Endothelial Cells - Artery, donor1	11264-116G4	34.32	20.94	3.20	1.16	4.65
Endothelial Cells - Artery, donor2	11341-117F9	57.41	31.29	3.53	2.12	2.59
Endothelial Cells - Artery, donor3	11413-118E9	44.35	39.97	4.21	2.45	3.16
Endothelial Cells - Lymphatic, donor1	11236-116D3	65.61	23.94	5.98	0.22	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	28.60	12.78	1.52	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.04	7.61	1.69	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	94.79	29.12	5.05	2.67	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	120.27	72.37	9.89	0.52	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	50.48	16.87	2.98	0.71	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	98.03	34.01	5.20	4.40	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	96.44	28.83	6.29	1.05	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.41	25.47	3.11	3.35	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.27	30.63	5.21	1.09	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.23	29.07	3.42	2.08	1.83
Endothelial Cells - Vein, donor1	11267-116G7	36.40	71.66	4.55	3.41	6.83
Endothelial Cells - Vein, donor2	11344-117G3	56.58	37.72	8.38	1.40	2.10
Endothelial Cells - Vein, donor3	11416-118F3	45.69	36.90	5.34	1.57	2.67
Eosinophils, donor1	12244-129H3	152.47	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	23.10	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	79.65	33.47	8.31	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	110.25	20.80	2.08	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.74	14.78	4.93	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.07	23.21	5.36	0.88	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	32.61	21.67	3.47	2.17	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	55.67	25.59	2.79	1.58	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.29	17.06	2.05	0.41	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	49.25	23.31	3.06	0.32	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.19	10.01	0.53	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.92	21.26	2.66	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	44.91	38.10	6.35	0.91	2.72
Fibroblast - Cardiac, donor2	11345-117G4	78.83	65.18	1.52	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	35.17	23.03	4.57	1.26	1.73
Fibroblast - Cardiac, donor4	11452-119A3	23.95	11.21	1.82	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	52.03	25.25	2.66	0.63	1.78
Fibroblast - Cardiac, donor6	11460-119B2	54.88	35.02	2.58	1.36	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	74.63	13.67	1.34	0.80	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.40	12.08	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	64.45	32.23	2.93	0.00	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	57.89	32.29	1.15	0.46	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	74.12	8.31	1.36	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	30.05	35.22	6.34	0.94	1.64
Fibroblast - Dermal, donor2	11346-117G5	53.77	69.81	8.02	1.89	2.83
Fibroblast - Dermal, donor3	11418-118F5	41.22	28.53	3.26	0.73	1.33
Fibroblast - Dermal, donor4	11450-119A1	51.10	40.70	2.15	2.03	1.70
Fibroblast - Dermal, donor5	11454-119A5	67.16	48.15	2.09	2.27	1.92
Fibroblast - Dermal, donor6	11458-119A9	65.94	46.13	2.60	3.90	1.79
Fibroblast - Gingival, donor1	11237-116D4	53.72	28.11	3.12	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.18	26.46	3.41	1.57	0.52
Fibroblast - Gingival, donor2	11318-117D4	60.23	36.11	0.92	2.24	0.66
Fibroblast - Gingival, donor3	11394-118C8	25.04	11.99	1.45	0.48	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	46.75	14.54	3.12	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.65	15.15	1.76	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.69	32.43	5.30	1.40	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.95	43.00	3.38	1.76	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.41	14.12	1.41	2.82	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.12	34.95	3.07	2.05	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.72	27.41	3.68	2.59	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.96	44.65	2.41	3.62	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.66	18.34	2.93	1.03	0.00
Fibroblast - Lung, donor1	11270-116H1	57.09	73.40	1.36	4.08	2.72
Fibroblast - Lung, donor2	11347-117G6	26.86	10.45	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	35.88	28.07	1.69	2.11	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	83.30	25.82	0.83	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	75.53	34.97	4.20	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	47.30	30.23	0.56	0.56	0.84
Fibroblast - Mammary, donor1	11540-120B1	46.28	25.98	2.03	0.41	1.62
Fibroblast - Mammary, donor2	11620-122A9	35.95	51.92	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	35.74	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	73.71	51.60	1.55	1.94	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.53	25.03	1.06	1.97	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.67	13.16	2.14	2.14	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	17.17	0.76	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	60.48	31.32	2.97	0.54	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.59	14.96	3.02	1.04	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	62.34	43.66	3.32	1.66	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.65	21.13	2.03	1.83	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	63.48	46.77	1.34	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.54	30.05	3.16	0.40	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	18.85	11.11	0.40	1.19	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	69.27	17.05	2.66	1.78	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	69.77	13.80	2.76	1.58	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	22.56	20.46	0.60	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	60.78	22.24	2.16	1.51	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.22	15.44	1.01	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	54.15	18.54	2.30	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.05	16.04	0.40	1.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	58.07	19.69	2.11	1.61	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	24.78	25.09	1.51	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	63.87	17.98	2.98	1.08	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	125.82	20.00	2.22	1.54	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.51	17.74	1.31	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	52.94	24.39	3.09	0.96	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	51.79	26.48	2.87	1.86	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.83	16.15	2.67	2.35	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	51.42	11.33	4.36	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.34	29.64	20.98	1.21	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.09	16.40	7.03	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.70	12.78	10.99	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	122.49	61.24	3.83	8.42	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	176.11	79.76	3.19	9.57	6.38
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	135.22	70.75	1.43	11.98	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	137.33	19.58	0.55	2.21	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	85.62	20.78	3.42	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	79.05	44.98	2.38	8.12	3.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	121.86	20.88	1.85	2.11	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	82.52	23.16	2.94	1.96	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	129.13	59.26	3.10	15.92	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	70.24	18.51	1.84	2.69	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.48	14.41	2.09	1.35	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	68.23	18.27	0.54	4.30	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.79	10.04	0.62	1.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	57.59	17.16	1.94	2.91	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	64.45	23.38	1.42	1.42	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	69.82	14.38	0.68	2.51	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	53.94	13.95	1.62	1.62	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.87	13.55	1.31	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	82.44	13.89	2.36	2.66	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.66	11.92	1.27	1.27	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	58.31	13.41	1.12	1.56	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.09	10.28	0.60	2.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	56.49	7.97	1.19	1.36	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.82	11.70	1.51	2.39	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.11	5.31	0.83	1.87	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.36	7.51	0.00	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	40.61	7.08	1.22	1.66	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.41	7.82	1.41	1.91	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.15	6.53	0.61	2.04	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	70.14	8.25	0.41	0.62	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.08	7.72	0.81	0.58	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.19	9.17	0.83	1.67	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.31	6.17	0.44	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.17	6.15	0.86	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.39	8.59	0.32	1.62	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	57.73	7.38	0.00	1.60	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.71	6.25	0.66	0.85	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.18	9.33	1.11	1.58	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.79	6.69	0.30	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	46.52	7.74	1.25	1.36	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.33	8.34	1.98	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	46.01	6.73	0.84	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.18	8.33	2.22	0.83	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.01	11.23	0.80	2.67	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.91	9.95	1.38	2.45	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.33	8.16	0.39	1.17	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.57	7.32	0.54	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.55	9.40	0.55	1.11	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.50	7.46	1.75	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	3.97	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.26	5.01	1.45	1.71	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.33	8.27	1.01	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.82	0.76	0.51	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	99.53	23.29	2.19	3.98	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	59.63	14.95	1.69	1.69	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	57.90	21.07	1.64	3.48	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	198.40	52.57	4.69	5.95	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	204.01	66.97	4.80	5.65	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	154.04	53.50	2.31	1.84	4.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	118.79	51.97	2.47	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	163.23	70.40	0.77	3.87	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	168.47	85.04	8.02	3.21	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	144.32	38.25	0.00	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	168.27	51.75	1.95	1.95	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	143.31	56.83	2.06	5.35	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	26.66	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	130.88	44.18	1.40	1.68	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	125.83	35.30	1.31	0.98	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	72.98	24.33	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	152.99	32.13	0.00	1.91	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	144.70	40.42	2.72	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	121.11	41.76	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	211.90	41.23	2.86	0.57	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	140.89	28.12	1.18	1.48	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	88.10	38.97	0.00	1.69	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	151.60	43.49	1.24	2.49	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	136.93	29.23	3.68	1.84	2.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	31.61	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	128.78	28.83	0.77	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	145.06	20.86	1.63	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	110.36	22.07	1.34	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	189.55	24.66	0.77	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	130.43	21.91	0.34	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	14.91	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	182.13	17.93	2.36	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	164.75	21.73	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	109.87	17.80	1.02	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	149.56	13.96	0.80	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	186.98	19.73	1.97	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	247.89	38.95	4.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	207.12	23.34	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	182.57	22.38	2.19	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	136.48	10.17	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	131.32	23.28	0.60	1.19	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	149.94	24.75	3.40	1.46	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	68.48	9.13	0.00	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	33.27	27.44	3.33	0.83	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	38.23	93.33	7.87	3.37	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	71.36	27.59	3.49	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	91.49	40.10	2.92	0.84	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.63	45.60	4.53	2.44	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	53.51	42.03	3.21	2.03	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	51.64	39.81	2.96	1.82	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	58.04	48.75	7.21	2.62	3.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	50.72	39.11	3.22	1.72	3.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.79	45.21	3.66	2.15	3.44
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.88	43.59	3.86	1.00	3.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	51.64	33.45	3.26	2.74	2.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	47.42	37.48	5.45	2.88	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.39	29.10	6.16	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.91	35.92	1.30	3.90	3.46
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	34.37	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	71.96	37.74	3.88	0.71	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.75	30.51	4.36	1.45	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	54.03	42.14	2.62	1.92	3.67
Hepatocyte, donor1	11523-119I2	15.74	10.90	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	33.40	10.77	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	19.02	15.95	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.99	43.08	1.96	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	73.93	13.28	0.70	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.04	29.50	2.06	1.37	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	79.60	6.37	6.37	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	86.78	40.05	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	81.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	76.14	2.77	6.92	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	42.55	0.00	7.51	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	154.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	87.14	2.56	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	54.85	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	68.22	3.25	11.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	86.70	1.67	8.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	54.46	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	34.41	91.32	1.32	10.59	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	77.61	3.33	12.20	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	57.62	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	87.55	64.25	1.89	8.19	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	57.23	91.25	1.55	12.37	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	58.54	0.00	29.27	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	73.65	63.96	3.88	8.40	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	56.35	75.67	1.61	9.66	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	47.79	11.95	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	81.49	67.63	4.89	8.96	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	57.51	60.87	2.10	7.98	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	43.12	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	86.80	77.96	4.02	7.23	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	72.94	2.77	7.39	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	63.73	64.20	3.78	3.30	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	55.33	72.56	0.91	7.26	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	88.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	65.64	80.71	2.15	15.07	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	49.55	74.96	2.54	10.16	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	40.81	59.94	2.55	10.20	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	40.10	87.49	5.47	9.11	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	173.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.13	53.55	5.00	9.28	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	112.82	3.32	6.64	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	74.70	54.02	2.78	4.63	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	43.90	91.31	3.51	12.29	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	62.86	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	61.19	58.41	6.95	7.65	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	59.75	0.00	13.28	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	81.05	3.24	6.48	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	63.65	54.93	0.87	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	65.24	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	52.27	3.48	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	94.94	66.14	4.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	44.33	73.43	1.39	5.54	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	42.74	8.55	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	74.55	67.19	2.76	4.60	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	75.63	96.81	3.03	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	68.30	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	83.53	58.16	1.06	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	45.12	13.95	5.96	0.49	0.57
Keratinocyte - epidermal, donor2	11349-117G8	46.27	31.62	12.30	0.00	2.34
Keratinocyte - epidermal, donor3	11421-118F8	33.13	16.28	4.83	0.76	1.61
Keratinocyte - oral, donor1	11251-116E9	74.13	26.90	5.68	0.23	1.25
Keratocytes, donor1	11527-119I6	97.99	40.92	3.44	1.03	2.75
Keratocytes, donor2	11607-120I5	46.87	52.73	3.52	1.17	3.52
Keratocytes, donor3	11688-122I5	54.73	10.67	0.79	0.99	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	4.40	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	49.62	40.99	2.16	0.00	3.24
Lens Epithelial Cells, donor2	11609-120I7	84.19	15.69	1.15	1.04	0.58
Lens Epithelial Cells, donor3	11690-122I7	45.61	23.11	4.04	0.91	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	68.54	22.53	2.25	1.19	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	88.47	30.14	0.56	1.12	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	80.12	30.07	2.20	1.57	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	105.93	41.40	3.23	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	89.19	35.30	3.78	0.95	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	90.78	30.73	4.53	0.75	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	97.67	38.17	3.28	1.64	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	116.80	37.16	4.05	1.01	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	91.63	25.48	4.36	0.99	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	106.40	43.11	5.54	1.19	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	88.60	29.08	4.85	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	118.31	36.10	4.63	1.11	2.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	111.50	34.84	3.83	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	82.05	28.15	2.39	0.72	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	89.69	27.61	3.71	0.96	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	99.78	34.80	3.70	0.62	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	100.07	34.29	2.49	1.56	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	93.33	32.94	3.29	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	90.18	33.90	4.94	0.99	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	111.58	30.17	4.98	2.05	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	116.50	37.59	2.24	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	113.48	35.40	4.85	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	87.79	25.31	1.89	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	83.11	27.25	3.33	1.06	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	115.61	36.29	10.37	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	77.47	28.06	3.56	2.09	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	83.46	28.57	3.16	1.20	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	112.81	47.46	5.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	93.89	30.86	2.26	2.07	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	83.23	28.42	4.14	1.17	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	90.13	33.44	6.78	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	115.11	34.40	1.32	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	79.79	26.51	4.21	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	103.66	38.87	3.70	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	94.14	29.65	3.71	0.74	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	104.50	25.85	4.12	0.69	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	91.67	31.52	2.57	1.29	2.25
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	85.52	22.82	4.56	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	95.32	27.85	3.22	0.70	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	103.82	36.62	6.04	1.42	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	128.95	24.24	2.42	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	94.45	36.72	3.42	1.71	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	127.13	42.61	5.37	1.79	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	84.61	27.44	2.94	0.98	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	111.36	37.43	5.89	1.18	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	72.15	22.65	1.98	0.74	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	95.28	30.99	2.82	1.54	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	69.22	26.85	3.28	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	86.11	36.26	11.33	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	56.77	32.22	6.90	6.90	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	48.24	29.69	1.48	3.71	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	76.16	41.89	2.54	5.08	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.01	32.35	2.81	1.41	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	60.71	33.62	3.74	3.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	66.47	38.13	4.12	4.12	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	66.61	40.44	3.57	7.14	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.98	22.62	6.79	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	65.15	36.35	4.07	4.07	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	54.92	36.01	4.95	4.50	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.94	22.22	3.12	5.83	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	69.33	37.49	4.11	3.59	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	49.40	25.76	3.18	2.12	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	40.64	18.66	6.00	2.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	66.22	41.77	4.08	4.08	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.29	31.22	4.00	3.47	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	70.85	37.79	3.21	3.97	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	68.11	42.95	6.75	4.91	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	69.31	30.17	1.63	7.34	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	74.55	39.36	5.62	3.96	2.71
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	66.98	43.72	5.04	4.48	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	46.37	5.15	2.06	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	75.48	40.64	5.23	2.03	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	64.57	39.76	3.59	4.19	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	51.45	19.92	4.98	2.21	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	66.46	42.06	5.30	5.30	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	63.80	37.62	6.27	5.16	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	65.62	48.35	2.30	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	59.87	50.27	7.68	4.61	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	54.35	53.78	7.93	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.95	34.46	9.03	4.10	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	75.92	44.74	7.68	2.26	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	66.07	49.55	4.31	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	36.60	22.41	8.22	5.23	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.49	38.27	7.80	2.60	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	62.46	40.49	6.03	2.58	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.95	37.68	5.14	3.43	4.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	61.64	46.64	9.66	6.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	62.74	48.26	4.83	2.41	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	48.35	44.08	6.40	4.98	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	77.34	37.81	4.81	3.78	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	64.95	49.92	6.98	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	56.56	44.44	2.69	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.90	50.75	5.19	6.30	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	88.38	44.19	2.33	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	45.48	33.85	7.40	5.29	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	81.23	34.41	7.60	2.40	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	59.60	39.25	6.54	3.63	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.15	47.52	5.37	9.20	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	72.02	50.81	5.92	6.41	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	53.63	31.05	3.76	6.59	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.40	38.72	5.53	8.05	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	64.44	43.26	3.15	3.60	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	46.47	6.88	6.88	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	70.36	41.42	5.79	4.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	68.82	36.76	7.82	7.43	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	61.36	40.90	6.60	2.64	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	65.38	46.70	6.75	7.26	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	52.51	33.69	5.69	3.94	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	60.38	40.81	7.27	4.47	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	61.83	43.28	7.07	3.97	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	74.83	45.13	6.17	2.70	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	61.27	43.55	7.60	2.53	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	57.19	40.37	3.84	3.84	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.00	41.34	3.18	3.18	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	65.02	34.63	3.04	2.43	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	60.87	40.12	6.23	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	65.74	45.60	4.56	8.36	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	67.13	49.58	5.68	6.71	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.05	35.67	5.44	2.42	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.23	46.58	5.39	2.85	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	67.17	39.45	4.80	3.73	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	71.26	47.70	5.75	4.02	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	78.68	48.34	2.57	8.74	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	56.59	39.61	6.37	3.54	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	76.04	56.18	5.67	4.54	3.97
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	66.15	41.19	3.33	4.16	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	49.33	39.15	3.13	5.48	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.71	47.18	5.01	5.43	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	59.94	50.65	3.25	3.25	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	48.84	46.16	4.01	6.02	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.25	54.00	3.74	3.21	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	59.00	49.70	6.47	4.04	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	54.15	41.30	4.59	5.51	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	87.13	48.90	8.00	4.45	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	54.71	42.74	3.42	5.70	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	51.38	36.04	4.60	6.14	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	58.00	40.49	5.47	4.38	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	41.87	6.68	6.68	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	65.25	39.77	3.64	2.34	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	79.57	62.33	7.96	5.30	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	60.28	2.08	8.31	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.45	8.43	2.96	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	13.95	5.69	1.47	0.18	0.55
Macrophage - monocyte derived, donor3	11389-118C3	18.48	12.19	2.23	0.00	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.92	48.85	31.86	0.53	2.12
Mallassez-derived cells, donor2	11929-125I3	74.31	31.85	7.92	0.63	0.48
Mallassez-derived cells, donor3	11930-125I4	88.26	43.50	13.62	0.28	1.25
Mammary Epithelial Cell, donor1	11273-116H4	70.55	23.32	7.17	0.60	1.20
Mammary Epithelial Cell, donor2	11350-117G9	55.30	23.16	4.92	0.58	1.74
Mammary Epithelial Cell, donor3	11422-118F9	51.13	55.12	14.97	1.50	1.50
Mast cell - stimulated, donor1	11487-119E2	11.52	7.46	1.36	2.71	0.00
Mast cell, donor1	11563-120D6	31.69	14.06	4.43	0.54	0.00
Mast cell, donor2	11565-120D8	23.18	5.35	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	31.29	9.00	0.90	0.68	0.23
Mast cell, donor4	11567-120E1	24.29	7.62	2.30	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	24.51	21.74	3.33	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	36.19	19.26	4.67	2.33	0.00
Mast cell, expanded, donor5	11939-126A4	29.94	23.75	7.80	0.80	0.23
Mast cell, expanded, donor8	11941-126A6	38.66	16.40	9.37	1.00	0.17
Melanocyte - dark, donor1	11502-119F8	49.35	13.93	2.49	0.90	0.70
Melanocyte - dark, donor2	11582-120F7	67.83	37.72	2.77	0.69	2.08
Melanocyte - dark, donor3	11663-122F7	29.27	13.55	1.88	0.72	0.72
Melanocyte - light, donor1	11274-116H5	15.28	10.11	1.18	0.47	0.47
Melanocyte - light, donor2	11351-117H1	34.81	21.16	4.78	1.36	0.68
Melanocyte - light, donor3	11423-118G1	21.68	32.95	2.60	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.61	17.60	1.98	0.94	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	65.08	25.01	5.38	1.88	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	42.86	23.57	2.95	0.00	0.27
Meningeal Cells, donor1	11493-119E8	54.59	27.67	1.61	2.36	0.74
Meningeal Cells, donor2	11573-120E7	74.83	38.29	2.20	3.96	1.32
Meningeal Cells, donor3	11654-122E7	42.14	27.38	1.79	3.99	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	66.16	43.34	3.14	1.43	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.55	20.33	4.23	0.60	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	43.37	13.14	6.57	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	45.79	69.33	9.16	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	36.60	46.64	4.31	2.87	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.58	16.09	2.75	1.27	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.61	19.60	3.02	0.50	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	66.37	50.98	1.76	3.08	2.42
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	52.60	59.18	2.19	1.46	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.25	58.11	3.27	1.23	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	102.36	26.87	3.05	0.69	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	69.88	17.47	1.12	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	85.65	11.84	0.26	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	86.94	15.43	1.78	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	23.36	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	78.77	49.95	3.84	3.84	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	70.89	60.61	4.96	0.35	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	117.27	11.88	0.63	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	74.75	89.26	4.35	7.26	0.73
Mesothelial Cells, donor1	11247-116E5	30.23	21.74	5.57	0.00	0.80
Mesothelial Cells, donor2	12156-128G5	33.53	30.03	8.51	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	20.16	14.53	2.82	0.36	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	13.50	4.05	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.16	14.28	4.93	0.25	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.80	15.61	2.65	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.04	9.30	4.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.78	9.33	4.15	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	23.52	8.26	3.75	0.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.72	13.50	3.26	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.20	10.77	3.25	0.41	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.57	9.50	7.13	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	26.55	10.62	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	17.10	3.80	0.38	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	6.58	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.68	8.28	1.49	0.00	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	5.52	2.76	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	19.37	2.68	3.28	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.10	6.77	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.91	7.37	2.38	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	6.08	2.21	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.28	7.14	2.07	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.67	9.25	3.37	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.78	5.30	2.04	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.38	8.15	1.50	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.34	8.22	1.78	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.99	6.35	2.19	0.00	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	6.59	3.04	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	8.28	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.69	5.16	1.90	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.53	8.23	3.53	0.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	2.18	2.18	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	12.97	1.92	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.61	10.81	2.40	0.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	15.02	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	12.26	2.63	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	14.35	1.10	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	3.20	3.84	0.64	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	17.85	8.43	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	6.26	3.48	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	11.05	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.04	5.47	2.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	7.88	2.63	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.39	4.97	2.13	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.16	7.01	1.12	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	8.73	4.16	0.42	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	1.75	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	8.14	2.41	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	23.37	13.77	7.10	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	5.54	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.63	7.40	3.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.92	3.32	1.66	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	8.03	0.52	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.02	10.30	3.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	7.62	1.91	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	3.74	1.07	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.46	5.99	3.29	0.30	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.45	2.54	0.28	0.00	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.29	4.14	1.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.80	9.95	4.42	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	5.31	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.21	3.13	0.85	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.37	11.55	1.97	0.49	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	1.30	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.58	4.41	1.18	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.91	8.65	4.04	0.00	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	2.89	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	13.10	2.98	0.89	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	15.07	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	1.78	3.56	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.71	4.27	1.31	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	5.26	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.68	4.35	0.59	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	9.31	3.73	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	21.78	3.76	1.88	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.84	9.85	2.13	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.37	5.66	0.90	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	5.89	6.63	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.86	2.93	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	3.11	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	44.89	8.02	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	7.07	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.44	7.17	0.42	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	54.48	1.36	2.72	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	99.18	9.54	3.18	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	108.52	11.34	4.05	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	12.08	6.04	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	5.71	34.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	127.24	9.79	26.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	50.20	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.32	21.33	1.94	1.08	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.99	8.88	2.09	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	19.36	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	10.43	4.59	1.67	2.92
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.31	20.73	2.66	5.13	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	71.81	12.77	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	20.40	3.40	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	12.86	0.00	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.53	9.63	2.51	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	25.10	5.81	1.16	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.43	20.81	2.16	1.62	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.43	22.71	3.57	1.68	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.87	26.80	2.98	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.65	16.78	4.60	1.89	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.83	17.68	4.08	0.45	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.98	17.31	3.27	0.82	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	47.57	23.69	5.10	0.91	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	16.44	4.24	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	12.61	4.80	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	29.54	12.80	4.59	4.92	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.03	14.64	3.42	0.65	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.39	19.05	2.29	1.06	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	15.47	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	12.87	5.06	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.50	21.21	3.53	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	35.52	16.90	2.76	2.07	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	2.53	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	40.77	14.26	4.90	1.11	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.43	11.01	2.54	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.77	13.29	4.75	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.03	15.02	3.86	1.29	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	36.11	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.33	13.33	2.33	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	31.11	13.08	4.06	0.00	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.28	14.28	5.56	0.79	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	27.86	3.71	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.97	20.05	3.78	0.00	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	14.66	2.61	0.65	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	11.33	2.18	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.20	16.73	4.98	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	17.64	2.65	2.65	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	19.28	2.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	13.39	5.95	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	5.74	2.68	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.85	20.26	4.23	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.90	22.77	3.09	0.22	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	8.81	3.39	0.00	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	18.90	4.88	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.50	8.18	2.52	1.26	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	8.78	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	11.08	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	13.60	2.27	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	47.95	39.01	5.59	1.24	1.61
Myoblast, donor2	11322-117D8	46.41	29.34	4.79	1.34	0.58
Myoblast, donor3	11398-118D3	29.26	22.20	4.88	1.68	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	38.38	23.64	0.58	0.58	0.29
Natural Killer Cells, donor1	11230-116C6	100.25	8.30	0.31	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	95.59	7.84	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	61.66	5.89	1.10	1.66	0.18
Neural stem cells, donor1	11275-116H6	29.76	5.08	0.73	2.54	0.73
Neural stem cells, donor2	11352-117H2	25.03	5.78	0.00	3.85	0.00
Neurons, donor1	11494-119E9	63.72	21.62	2.28	3.41	0.00
Neurons, donor2	11574-120E8	53.28	15.41	0.66	1.32	0.66
Neurons, donor3	11655-122E8	60.02	8.22	1.64	4.11	2.47
Neutrophils, donor1	11233-116C9	2.78	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	49.99	6.89	0.95	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	35.82	14.33	2.28	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	110.50	37.30	3.61	0.40	2.61
Olfactory epithelial cells, donor1	11933-125I7	34.41	13.21	2.20	1.38	0.41
Olfactory epithelial cells, donor2	11934-125I8	39.52	19.54	2.17	1.74	0.43
Olfactory epithelial cells, donor3	11935-125I9	45.52	17.48	2.16	1.70	0.91
Olfactory epithelial cells, donor4	11936-126A1	50.45	16.95	3.12	1.17	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	46.34	27.68	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	75.72	26.59	8.30	0.64	1.06
Osteoblast - differentiated, donor2	11353-117H3	97.16	50.30	12.57	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	95.59	21.72	5.59	0.62	1.24
Osteoblast, donor1	11277-116H8	92.64	70.55	6.64	1.95	0.98
Osteoblast, donor2	11354-117H4	31.60	22.47	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	44.08	56.70	6.93	1.96	2.84
Pancreatic stromal cells, donor1	11249-116E7	48.35	22.07	3.71	2.19	0.51
Pericytes, donor1	11491-119E6	57.52	13.46	1.00	0.89	0.00
Pericytes, donor2	11571-120E5	58.40	12.45	2.94	0.45	0.68
Pericytes, donor3	11652-122E5	74.87	48.01	6.71	1.83	3.05
Perineurial Cells, donor1	11499-119F5	59.90	17.07	1.47	1.36	1.02
Perineurial Cells, donor2	11579-120F4	63.12	19.78	1.75	1.29	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	85.10	7.65	0.32	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	51.42	9.06	0.24	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	39.34	5.95	0.26	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	93.99	92.32	22.24	1.20	2.63
Placental Epithelial Cells, donor2	11355-117H5	84.28	32.16	9.98	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	54.78	23.95	3.93	0.59	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.24	16.77	5.70	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	51.77	19.13	4.13	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.92	10.44	0.78	1.04	0.13
Preadipocyte - breast, donor2	11328-117E5	46.61	22.51	4.50	0.23	1.13
Preadipocyte - omental, donor1	11468-119C1	47.10	16.09	4.05	0.75	0.32
Preadipocyte - omental, donor2	11329-117E6	24.01	12.66	2.62	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	36.67	22.78	4.15	0.29	1.43
Preadipocyte - perirenal, donor1	11469-119C2	71.85	38.39	6.89	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	46.68	75.24	6.76	0.92	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	44.98	40.55	1.95	1.95	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	32.01	32.01	4.77	0.68	1.53
Preadipocyte - visceral, donor1	11280-116I2	36.14	30.55	2.89	2.51	0.47
Preadipocyte - visceral, donor2	11357-117H7	26.23	28.99	2.30	1.84	0.92
Preadipocyte - visceral, donor3	11429-118G7	59.66	50.47	4.91	1.25	1.67
Prostate Epithelial Cells (polarized), donor1	11253-116F2	84.33	7.54	0.75	1.06	0.60
Prostate Epithelial Cells, donor2	11331-117E8	30.33	16.39	6.64	0.54	2.03
Prostate Epithelial Cells, donor3	11404-118D9	37.23	8.21	1.41	0.37	0.49
Prostate Stromal Cells, donor1	11254-116F3	56.95	32.35	3.30	1.59	0.80
Prostate Stromal Cells, donor2	11332-117E9	47.69	36.58	3.23	1.26	1.97
Prostate Stromal Cells, donor3	11405-118E1	39.10	21.59	4.48	1.36	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	61.32	32.85	2.92	1.09	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	66.54	18.51	1.87	1.32	0.62
Renal Epithelial Cells, donor1	11517-119H5	35.00	49.20	2.03	2.54	1.52
Renal Epithelial Cells, donor2	11597-120H4	56.19	52.64	1.42	3.56	2.13
Renal Epithelial Cells, donor3	11678-122H4	61.72	16.51	1.16	1.16	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.26	48.34	5.45	2.04	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	74.66	47.03	5.66	2.56	2.56
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.73	36.85	3.55	2.00	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	22.63	21.29	1.33	2.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	68.45	35.87	2.20	2.42	1.76
Renal Mesangial Cells, donor2	11598-120H5	62.07	31.35	3.13	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	52.43	30.79	2.50	2.50	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	77.57	49.93	3.22	1.61	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	48.92	43.43	0.84	0.84	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.42	46.09	4.44	2.31	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	88.16	58.86	5.44	2.85	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	73.62	29.28	1.71	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	39.11	41.16	3.09	4.12	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	110.40	14.30	0.75	2.01	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	35.28	7.75	1.07	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	32.16	12.51	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	38.53	9.36	0.00	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.06	3.48	0.00	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	65.40	5.20	0.26	0.78	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	45.58	8.34	0.89	1.39	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	61.79	14.61	0.89	1.56	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	50.73	10.92	0.62	0.50	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.57	9.91	1.52	1.52	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	68.88	12.94	1.39	0.46	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	45.32	8.08	0.41	0.27	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	42.96	8.62	0.45	0.30	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	67.38	15.95	1.43	0.54	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	57.10	10.04	0.29	0.43	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.97	7.94	1.18	1.07	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.50	15.71	1.55	0.89	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.53	11.47	0.19	1.15	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	42.85	7.73	0.37	1.40	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.33	8.64	0.94	0.56	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	43.53	10.22	0.40	1.19	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.76	10.71	0.58	0.29	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.60	11.84	1.53	0.95	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.64	9.18	0.11	1.39	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.93	9.81	0.00	0.56	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	52.64	10.42	0.51	0.85	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	58.53	7.29	0.55	0.91	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	42.19	7.11	1.23	1.23	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	59.91	11.95	1.21	0.54	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	69.82	8.96	1.18	0.71	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.99	9.33	1.19	0.40	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	67.82	13.10	1.87	0.47	3.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.69	7.88	1.24	1.04	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.58	8.63	1.55	1.33	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	64.75	11.70	1.25	0.84	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	44.41	9.02	0.27	2.29	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	40.87	8.00	0.51	1.70	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	46.85	15.81	0.77	0.58	3.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	55.19	11.86	0.34	1.55	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.04	8.09	0.55	1.10	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.83	9.19	2.30	0.82	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	40.56	5.79	0.34	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	41.72	11.69	0.59	0.59	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.98	7.73	0.53	0.27	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	37.33	5.95	0.14	0.83	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	66.19	11.19	0.00	0.24	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	44.54	4.03	0.20	0.60	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.52	6.40	0.57	0.75	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	52.75	12.58	0.00	1.05	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	44.73	13.00	0.60	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	46.51	8.32	1.22	0.49	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	45.27	6.70	0.73	0.58	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	53.54	12.17	0.61	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.27	9.95	0.30	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.45	8.14	1.13	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.06	4.49	1.50	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	51.95	4.60	0.59	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	47.81	6.40	1.28	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.24	6.61	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	72.97	65.64	2.63	2.07	3.01
Schwann Cells, donor2	11578-120F3	47.63	57.84	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	45.57	42.50	2.41	2.63	1.10
Sebocyte, donor1	11220-116B5	35.61	14.79	3.29	1.64	0.00
Sebocyte, donor2	11301-117B5	30.79	14.71	2.30	0.00	0.46
Sebocyte, donor3	11378-118B1	38.34	17.73	3.30	0.62	1.44
Sertoli Cells, donor1	11255-116F4	28.16	16.57	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	76.26	19.77	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	85.78	17.16	1.50	1.50	0.97
Skeletal Muscle Cells, donor2	11358-117H8	65.78	38.31	2.89	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	104.50	116.21	4.18	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	82.16	65.82	4.56	2.67	4.24
Skeletal Muscle Cells, donor5	11455-119A6	74.17	62.73	3.72	1.34	2.68
Skeletal Muscle Cells, donor6	11459-119B1	82.65	64.95	2.62	3.08	2.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	66.15	33.90	1.13	2.14	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	72.06	40.38	1.85	1.71	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.68	44.15	2.58	2.78	1.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	63.95	16.77	1.26	1.69	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	97.71	95.54	5.07	1.45	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	67.97	53.94	6.33	0.69	2.20
Skin - palm, donor1	10286-104F7	32.23	8.06	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	29.84	20.04	4.90	0.72	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	8.18	17.18	1.64	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.57	17.14	3.76	0.39	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	56.30	15.85	4.59	0.56	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	40.65	16.32	6.61	0.70	1.27
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	40.60	15.65	5.71	0.85	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	27.96	10.79	4.05	0.52	1.42
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	99.36	37.65	4.63	0.62	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.56	10.00	0.67	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.78	58.19	8.82	0.59	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	80.00	38.45	1.55	1.10	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	56.70	53.95	7.48	1.18	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	63.35	69.53	8.50	1.55	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	51.04	6.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	52.17	49.37	6.92	0.67	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	59.40	35.02	5.10	1.33	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	88.21	111.26	14.34	0.13	5.25
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.72	35.49	2.93	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	36.03	14.47	3.25	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.33	22.49	5.41	0.57	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	80.04	68.65	4.39	1.79	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	49.01	20.70	2.74	1.22	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	72.49	50.26	4.55	0.76	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	238.71	336.64	24.48	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	82.97	97.75	6.20	0.48	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	74.18	39.38	5.01	1.03	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	78.13	41.33	2.80	2.37	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.29	41.46	3.15	1.78	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.82	56.46	8.04	1.39	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	95.93	150.90	11.86	0.00	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	84.28	79.50	8.97	0.60	3.29
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	79.20	66.57	4.78	2.73	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	88.74	10.60	0.94	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.28	16.00	3.02	0.70	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.65	25.03	5.01	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	109.29	125.59	13.28	1.81	6.04
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.32	57.49	2.65	4.24	2.91
Smooth Muscle Cells - Prostate, donor1	11257-116F6	56.73	24.63	2.93	2.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.84	30.18	3.01	1.38	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.32	10.40	2.79	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	59.56	37.54	4.37	1.21	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	64.51	48.76	6.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	540.15	112.42	14.21	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	56.74	49.76	6.05	4.65	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	49.98	42.91	3.03	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	60.49	94.02	10.66	0.94	3.76
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	64.31	59.59	2.06	0.00	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	97.72	59.98	4.50	1.42	1.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	49.52	18.69	3.27	0.93	3.74
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	45.77	48.50	9.64	0.86	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	61.70	81.84	8.41	0.00	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	67.13	79.73	6.39	0.94	2.63
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	49.75	29.35	2.52	3.63	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	88.40	27.99	2.51	0.50	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	36.19	26.19	2.86	1.90	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	48.44	52.85	11.99	0.24	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	62.75	29.17	3.76	0.88	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	42.72	34.52	3.51	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.35	12.44	2.92	1.94	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.49	29.35	4.50	0.53	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.74	20.83	4.46	1.49	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	49.59	32.70	7.19	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.88	59.05	12.78	1.14	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	39.78	33.08	4.73	2.76	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	42.16	24.13	3.30	1.27	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	46.32	18.37	4.79	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	61.45	29.68	4.60	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	53.63	26.58	6.88	0.92	0.00
Synoviocyte, donor1	11291-117A4	43.43	10.27	2.19	0.17	0.50
Synoviocyte, donor2	11368-117I9	37.72	17.60	2.85	0.50	1.17
Synoviocyte, donor3	11440-118H9	58.76	18.10	3.57	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	60.39	38.59	1.43	3.57	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	59.46	3.96	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	30.80	29.64	1.16	2.32	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	50.04	20.93	8.89	0.14	1.08
Tracheal Epithelial Cells, donor2	11369-118A1	47.16	52.19	21.26	1.16	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	93.92	42.38	18.33	0.57	5.73
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.20	6.64	0.49	0.62	0.00
Urethra, donor2	10319-105A4	17.98	5.40	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	79.70	29.75	5.31	0.00	1.59
Urothelial Cells, donor2	11600-120H7	65.29	25.64	4.01	0.00	2.40
Urothelial Cells, donor3	11681-122H7	60.05	22.92	3.90	0.00	0.92
Urothelial cells, donor0	11216-116B1	61.52	13.37	3.34	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	81.86	13.35	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	121.52	14.30	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	53.39	6.16	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	67.49	8.61	0.00	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	82.51	8.72	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	103.08	3.12	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	107.38	15.60	0.92	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	65.73	10.04	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	46.38	19.61	0.99	1.60	2.10
Wilms' tumor cell line:HFWT	10597-108E3	67.76	16.72	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.48	6.70	1.96	0.00	0.56
achilles tendon, donor2	10292-104G4	20.67	6.20	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	100.71	44.62	1.53	2.80	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	91.24	42.72	3.25	3.48	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	78.47	14.48	1.19	1.66	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	70.75	46.53	2.72	7.89	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	55.65	21.08	0.28	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	101.93	21.15	5.08	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	186.74	21.23	5.44	3.27	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	155.10	15.42	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.15	18.78	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	80.38	48.54	3.11	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	82.06	62.38	2.02	5.70	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	113.11	23.40	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	100.16	35.79	2.56	1.16	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	124.27	74.05	4.66	5.44	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	81.54	40.91	1.75	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	47.87	25.56	4.18	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.08	22.62	2.06	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.28	27.63	4.30	2.76	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	52.49	30.72	1.71	3.41	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	58.54	40.94	2.73	2.43	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	59.45	30.81	3.85	3.37	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	54.57	31.18	2.23	2.23	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	65.38	38.36	3.67	1.00	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	100.34	81.76	1.86	3.72	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	91.53	70.06	3.39	4.14	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.11	21.37	2.18	3.49	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	54.36	11.25	0.00	7.50
adenocarcinoma cell line:IM95m	10796-110I4	49.93	21.67	1.18	0.24	2.83
adipose tissue, adult, pool1	10010-101C1	22.34	4.65	1.24	0.31	0.62
adipose, donor1	10184-103D4	168.89	8.21	4.10	2.35	0.00
adipose, donor2	10185-103D5	70.97	10.54	1.22	1.62	1.22
adipose, donor3	10186-103D6	67.53	20.15	3.00	2.45	0.82
adipose, donor4	10187-103D7	129.15	26.00	6.93	5.20	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	37.40	29.35	2.21	1.58	2.37
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	46.03	12.27	2.13	0.40	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	55.02	62.17	2.50	1.79	0.36
amniotic membrane cells, donor1	12235-129G3	21.10	9.27	0.46	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	57.82	22.31	11.50	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	38.30	8.54	1.18	0.29	0.29
amygdala - adult, donor10196	10167-103B5	5.93	4.74	1.19	1.19	1.19
amygdala, adult, donor10252	10151-102I7	15.82	5.27	0.00	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	19.04	4.84	1.29	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	42.53	3.69	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	98.18	95.31	13.24	5.07	5.52
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	65.14	12.03	0.00	0.00	0.67
aorta, adult, pool1	10052-101G7	13.14	5.69	1.18	0.00	0.39
appendix, adult	10189-103D9	28.33	13.97	1.16	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	72.23	23.04	2.41	3.10	0.69
artery, adult	10190-103E1	40.76	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	84.02	5.79	2.61	0.29	0.29
b cell line:RPMI1788	10427-106D4	83.27	14.72	3.42	0.00	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.80	15.54	3.88	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.46	22.92	1.59	0.60	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	58.25	7.03	0.17	0.17	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	159.94	34.67	2.24	1.12	0.56
bladder, adult, pool1	10011-101C2	28.68	3.69	0.33	0.22	0.00
blood, adult, pool1	10053-101G8	31.00	4.43	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	16.27	1.71	0.00	0.86
bone marrow, adult	10192-103E3	39.14	13.50	2.02	0.67	0.00
brain, adult, donor1	10084-102B3	4.10	4.10	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	12.14	2.90	0.56	0.56	0.00
brain, fetal, pool1	10085-102B4	32.06	13.36	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	54.18	35.68	2.97	1.65	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	28.71	3.87	0.25	0.87	0.37
breast, adult, donor1	10080-102A8	6.94	5.05	1.89	1.26	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.47	26.04	5.72	0.64	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	43.29	24.12	0.93	0.31	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	87.71	51.34	1.84	3.22	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	75.29	12.83	2.18	0.97	1.94
carcinoid cell line:NCI-H1770	10703-109H1	67.23	18.81	0.47	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.27	12.03	0.22	0.33	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	90.00	20.60	0.00	1.27	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	69.21	25.82	1.06	2.13	0.27
caudate nucleus - adult, donor10196	10177-103C6	10.36	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.07	4.52	0.33	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	14.52	3.82	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	21.24	10.25	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	10.46	2.56	0.00	1.49	0.64
cerebellum, adult, pool1	10083-102B2	5.86	2.41	0.34	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	22.42	2.49	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	10.84	5.04	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	16.08	10.23	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	65.56	10.50	1.01	0.43	1.01
cervical cancer cell line:ME-180	10553-107I4	67.28	11.77	4.47	0.66	0.99
cervix, adult, pool1	10013-101C4	33.07	4.20	0.84	0.21	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	49.88	29.96	1.95	2.23	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	9.14	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	140.31	19.76	1.49	1.86	1.24
choriocarcinoma cell line:SCH	10785-110H2	262.20	55.82	3.45	6.78	9.73
choriocarcinoma cell line:T3M-3	10618-108G6	78.27	48.62	2.85	1.19	1.19
chorionic membrane cells, donor1	12238-129G6	25.64	8.55	1.42	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	36.19	23.37	6.16	1.19	0.50
chorionic membrane cells, donor3	12240-129G8	34.07	7.69	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	144.40	85.83	6.06	5.05	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.58	41.49	2.11	0.77	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.62	41.60	2.75	1.90	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	53.93	51.62	2.31	3.08	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	55.15	55.39	2.42	1.94	2.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	55.38	42.76	0.81	3.26	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	98.35	75.38	2.36	2.94	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	80.79	23.98	2.61	8.08	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	65.15	45.03	0.69	1.14	1.37
clear cell carcinoma cell line:TEN	10636-108I6	36.44	14.40	0.35	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	62.97	19.04	1.46	2.01	1.46
colon carcinoma cell line:COLO-320	10420-106C6	51.31	5.70	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	13.09	5.95	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	40.54	7.29	1.53	0.35	0.94
colon, fetal, donor1	10070-101I7	14.83	3.09	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	13.75	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	150.22	150.22	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	60.34	27.20	8.50	3.82	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	78.94	46.34	7.55	2.26	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	81.36	46.53	6.35	3.24	0.71
corpus callosum, adult, pool1	10042-101F6	15.15	2.99	0.22	0.66	0.00
cruciate ligament, donor2	10295-104G7	29.18	11.35	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	4.01	0.00	0.00	1.61
diencephalon, adult	10193-103E4	11.28	3.36	0.48	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	106.08	52.35	4.36	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	93.60	18.21	3.33	1.28	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	75.83	12.04	1.20	0.24	0.00
ductus deferens, adult	10196-103E7	17.94	6.98	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.74	7.36	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	23.87	5.29	0.41	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	151.01	30.20	6.88	18.21	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	145.30	52.73	4.59	19.92	2.15
embryonic pancreas cell line:1B2C6	10604-108F1	50.56	23.43	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	52.67	23.01	1.51	2.12	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	43.84	25.63	1.54	1.54	0.93
embryonic pancreas cell line:2C6	10603-108E9	39.40	26.27	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	115.31	32.85	2.01	3.69	5.03
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	76.12	20.30	1.99	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	61.59	21.39	1.29	0.80	1.61
epidermoid carcinoma cell line:A431	10426-106D3	52.02	5.45	2.11	0.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	46.52	21.01	3.41	1.43	1.10
epididymis, adult	10197-103E8	19.05	3.98	1.05	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.08	24.13	1.24	0.89	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	51.12	32.64	1.57	0.39	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	45.47	30.27	1.57	1.18	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.73	21.95	1.28	1.18	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	41.79	32.49	1.57	1.46	1.90
esophagus, adult, pool1	10015-101C6	50.75	9.56	3.29	0.53	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	85.29	10.27	0.63	0.88	0.13
eye - muscle inferior rectus, donor1	10272-104E2	4.83	9.66	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	8.74	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	22.63	4.07	0.00	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	39.49	20.39	1.67	1.15	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.86	36.33	0.71	0.95	1.66
frontal lobe, adult, pool1	10040-101F4	7.22	2.44	0.28	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	56.45	18.92	1.50	2.40	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	44.35	9.69	0.18	0.18	0.27
gall bladder, adult	10198-103E9	21.73	9.17	1.93	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	148.71	22.01	2.68	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	89.26	13.82	1.12	1.49	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	43.09	15.42	1.27	2.32	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	233.65	46.23	0.77	2.13	4.06
gastric cancer cell line:AZ521	10549-107H9	97.06	45.91	1.80	3.61	1.80
gastric cancer cell line:GSS	10560-108A2	69.56	16.47	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.26	5.03	0.23	1.37	0.23
giant cell carcinoma cell line:LU65	10487-107B1	129.20	42.34	2.52	1.26	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	23.79	8.26	0.42	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	54.87	38.66	5.99	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	30.50	27.02	1.27	1.27	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.10	23.45	2.53	1.40	0.28
glioblastoma cell line:T98G	10485-107A8	40.84	28.03	1.99	0.44	0.22
glioma cell line:GI-1	10413-106B8	29.87	9.08	0.59	2.93	0.00
globus pallidus - adult, donor10196	10175-103C4	8.75	3.64	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	21.97	5.61	0.49	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	10.95	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.38	7.99	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	12.24	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	54.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	209.06	73.17	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.68	13.76	1.28	1.92	0.96
hIPS +CCl2, biol_rep1	14383-156B9	75.75	50.50	1.38	5.97	2.75
hIPS +CCl2, biol_rep2	14384-156C1	54.41	43.44	0.46	4.12	2.29
hIPS +CCl2, biol_rep3	14385-156C2	37.36	55.39	3.86	5.80	3.86
hIPS, biol_rep1	14380-156B6	10.06	84.80	5.75	5.75	7.19
hIPS, biol_rep2	14381-156B7	33.61	70.64	4.12	4.80	4.12
hIPS, biol_rep3	14382-156B8	15.45	8.83	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	54.02	14.65	5.17	3.16	1.44
heart - mitral valve, adult	10205-103F7	14.65	6.58	0.60	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	13.86	3.66	1.05	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	18.32	24.98	3.33	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	23.26	12.45	2.04	0.61	1.02
heart, adult, diseased, donor1	10051-101G6	14.05	2.13	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	11.96	6.90	0.92	0.46	0.00
heart, fetal, pool1	10046-101G1	27.93	2.88	0.31	1.44	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.83	16.97	2.78	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	71.35	3.57	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	67.73	15.47	2.10	2.54	4.86
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.69	15.66	2.18	3.16	4.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	62.15	15.87	1.82	4.14	3.94
hepatoma cell line:Li-7	10484-107A7	72.74	17.46	0.56	0.89	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.48	22.91	1.81	1.71	1.41
hippocampus - adult, donor10196	10169-103B7	3.79	4.73	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	15.72	4.29	0.00	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	2.99	4.98	0.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	10.57	7.05	0.70	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	150.14	62.87	1.83	8.54	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	151.00	68.53	3.34	6.09	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	113.24	66.27	3.55	5.84	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	143.79	20.30	1.13	3.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	171.19	25.30	0.77	1.55	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	224.73	35.30	2.28	1.90	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	97.51	24.82	0.88	4.96	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	120.64	23.70	1.72	1.94	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	98.43	31.28	3.34	3.34	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	116.50	28.18	1.66	2.37	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	112.34	23.14	3.21	3.05	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	103.02	18.85	4.04	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	124.09	61.97	3.13	5.95	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	97.28	71.73	2.95	5.40	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	193.75	75.06	6.98	13.09	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	140.32	20.05	0.95	1.72	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	107.27	18.32	0.44	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	112.45	23.49	1.50	3.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	114.17	14.88	0.57	1.13	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	100.49	16.37	1.82	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	103.68	16.60	1.57	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	95.20	17.47	1.47	1.31	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	87.38	15.39	2.32	1.16	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	77.42	12.55	1.20	3.29	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	136.71	60.97	4.06	4.62	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	107.84	58.20	3.14	7.42	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	139.23	66.55	5.31	10.21	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	106.33	27.11	1.06	2.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	102.62	19.00	0.63	1.27	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	117.42	29.96	1.82	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	76.02	16.55	0.52	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	94.31	12.62	0.66	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	91.84	16.42	1.80	2.57	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	80.02	21.22	0.51	2.56	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	108.28	17.42	0.76	4.54	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	69.56	22.85	2.35	5.38	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	137.90	65.45	3.62	5.80	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	151.97	71.75	1.78	5.35	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	118.54	64.88	1.95	2.44	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	114.61	16.50	0.92	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	309.06	29.28	0.00	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	158.52	31.11	0.66	1.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	132.45	21.34	1.64	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	116.89	15.56	1.81	2.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	139.15	27.76	2.14	2.85	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	124.11	31.03	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	70.69	11.10	1.49	4.06	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	84.59	15.89	1.62	4.31	0.81
immature langerhans cells, donor1	11904-125F5	63.93	6.05	1.45	0.24	0.00
immature langerhans cells, donor2	11905-125F6	76.84	8.71	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	9.56	3.41	0.09	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	29.26	6.18	2.28	0.65	1.95
kidney, adult, pool1	10017-101C8	19.32	6.11	0.70	0.10	0.00
kidney, fetal, pool1	10045-101F9	30.63	4.17	0.21	0.71	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	74.99	17.04	1.28	0.57	1.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	77.28	8.71	1.38	0.83	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	93.77	23.12	4.77	0.00	2.20
left atrium, adult, donor1	10079-102A7	6.54	1.09	0.54	0.00	1.09
left ventricle, adult, donor1	10078-102A6	6.57	2.53	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	56.36	28.18	1.09	1.92	3.83
leiomyoma cell line:10964C	10569-108B2	64.31	50.65	10.06	0.00	2.51
leiomyoma cell line:15242A	10570-108B3	40.76	53.80	10.33	1.09	1.09
leiomyoma cell line:15425	10571-108B4	33.75	45.89	5.58	0.73	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	50.79	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	66.92	44.96	5.23	2.09	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	85.95	28.81	2.60	4.37	1.65
liposarcoma cell line:KMLS-1	10782-110G8	32.34	24.21	2.66	1.41	0.62
liposarcoma cell line:SW 872	10726-110A6	24.00	9.26	0.37	1.10	0.73
liver, adult, pool1	10018-101C9	29.82	12.15	1.78	0.49	0.49
liver, fetal, pool1	10086-102B5	12.23	10.35	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	12.69	3.65	0.58	1.17	0.15
locus coeruleus, adult, donor10252	10165-103B3	18.64	4.43	0.00	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	5.08	3.39	0.00	1.41	0.28
locus coeruleus, newborn, donor10223	10362-105F2	16.82	3.79	0.00	4.63	0.42
lung adenocarcinoma cell line:A549	10499-107C4	63.11	41.66	2.49	1.66	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	45.50	19.99	4.83	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.64	13.97	0.66	0.40	1.32
lung, adult, pool1	10019-101D1	27.05	3.54	1.30	0.12	0.12
lung, fetal, donor1	10068-101I5	43.67	2.28	0.86	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	11.00	2.75	0.92	0.92	0.00
lymph node, adult, donor1	10077-102A5	28.88	11.83	0.95	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	69.70	32.88	5.92	0.88	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	58.26	31.54	2.26	1.21	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	46.72	3.40	1.70	0.85	0.85
mature adipocyte, donor1	12231-129F8	6.66	9.32	4.44	0.00	4.88
mature adipocyte, donor2	12232-129F9	9.34	8.92	2.91	0.42	4.15
mature adipocyte, donor3	12233-129G1	6.40	7.59	2.13	0.24	5.93
mature adipocyte, donor4	12234-129G2	16.32	6.05	2.11	0.00	5.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.70	13.10	1.19	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	3.38	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	10.85	2.02	0.37	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	8.58	3.18	0.32	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	10.24	0.00	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	16.03	3.54	0.17	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	17.19	2.55	0.21	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	5.74	0.36	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	8.44	4.54	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	12.69	5.11	0.77	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	10.61	2.37	0.24	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	19.44	7.29	0.00	3.12	0.00
medulloblastoma cell line:D283 Med	10838-111E1	94.99	9.52	0.44	0.66	0.66
medulloblastoma cell line:ONS-76	10759-110E3	38.64	22.99	3.79	2.45	2.81
melanoma cell line:COLO 679	10514-107E1	32.77	18.69	2.30	1.29	0.72
melanoma cell line:G-361	10465-106H6	105.33	18.73	1.36	1.63	1.09
meningioma cell line:HKBMM	10691-109F7	99.86	28.76	3.08	0.18	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	55.51	11.46	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	40.96	9.59	0.78	1.56	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	58.77	49.87	7.21	0.92	1.69
mesenchymal precursor cell - adipose, donor2	11748-123G2	58.17	22.18	2.73	0.91	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	69.98	39.75	4.14	1.66	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.35	20.79	2.53	0.42	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	57.77	19.26	2.70	0.96	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	50.67	31.93	2.08	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	64.02	26.43	6.35	0.51	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.71	23.92	3.11	0.58	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	48.81	31.57	3.98	1.19	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.13	31.19	3.11	1.35	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.43	29.16	3.41	1.00	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	55.66	26.02	3.95	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	38.61	32.79	4.29	0.42	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.36	45.03	6.98	2.09	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.04	27.56	5.10	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.25	25.88	3.95	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	37.14	20.07	2.90	0.72	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	34.88	29.64	5.24	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.66	31.89	1.26	0.00	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.31	22.71	3.74	1.64	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	37.90	25.03	4.20	0.96	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.56	14.73	1.10	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	39.20	21.18	3.43	0.57	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	38.73	46.31	4.21	4.21	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	50.69	28.77	5.02	0.91	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	42.97	26.86	2.56	1.79	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	41.36	26.44	3.40	1.05	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	54.53	29.58	4.01	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.95	24.95	2.12	1.18	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.63	27.75	3.38	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.12	22.79	1.96	0.79	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	54.22	28.27	0.93	2.32	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.09	27.40	3.17	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	39.27	28.11	3.35	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	54.56	27.40	3.12	0.72	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	46.20	19.80	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	41.62	27.52	5.37	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.22	28.25	3.68	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.24	24.48	2.15	3.01	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	65.63	65.63	8.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	51.65	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	64.31	42.87	8.44	1.62	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	65.47	27.64	5.82	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	81.56	41.58	7.46	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	61.33	37.62	5.72	0.00	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	62.97	29.15	6.22	2.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	77.65	54.57	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	76.50	43.71	3.97	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	38.14	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	61.08	36.17	4.15	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	56.05	25.59	4.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	63.97	32.30	6.33	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	79.67	26.56	4.83	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	70.92	25.79	8.60	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	11.98	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	20.66	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	68.45	15.48	2.04	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	75.47	26.22	3.18	1.59	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.05	18.28	2.95	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	65.15	15.59	3.43	0.94	4.05
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	82.87	12.03	0.00	1.34	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	18.92	4.73	0.00	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	46.22	10.27	5.14	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.69	18.59	8.95	0.00	8.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	53.44	19.79	8.91	0.49	13.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	22.43	4.49	0.00	17.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.34	27.99	7.63	0.64	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	33.04	16.12	11.69	0.00	14.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	37.07	19.63	0.00	23.99
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	38.01	29.14	11.40	0.00	12.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.31	15.78	7.89	0.00	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	18.08	4.52	0.00	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.01	19.77	9.88	2.47	10.71
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	55.16	17.46	6.55	0.00	3.57
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	45.10	19.47	3.89	0.32	8.11
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	52.97	21.39	5.09	0.00	9.17
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	17.80	4.64	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	50.08	42.76	0.71	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	105.64	40.08	8.11	3.24	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	8.55	8.55	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	105.73	38.53	2.77	4.73	2.36
mesothelioma cell line:Mero-25	10850-111F4	71.26	23.60	1.36	2.04	1.59
mesothelioma cell line:Mero-41	10851-111F5	50.85	31.29	1.47	0.49	1.22
mesothelioma cell line:Mero-48a	10852-111F6	40.96	35.65	3.10	0.00	2.21
mesothelioma cell line:Mero-82	10853-111F7	61.76	31.27	1.58	1.05	1.58
mesothelioma cell line:Mero-83	10854-111F8	55.49	37.62	3.23	0.68	1.87
mesothelioma cell line:Mero-84	10855-111F9	53.84	31.34	1.52	1.26	0.76
mesothelioma cell line:Mero-95	10856-111G1	49.90	24.64	1.24	0.21	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	45.55	34.12	4.31	1.82	1.82
mesothelioma cell line:NCI-H226	10846-111E9	66.42	36.38	4.34	1.27	2.90
mesothelioma cell line:NCI-H2452	10848-111F2	18.96	12.81	0.00	0.85	0.00
mesothelioma cell line:NCI-H28	10845-111E8	49.88	50.89	4.07	2.54	0.51
mesothelioma cell line:No36	10857-111G2	64.26	23.49	2.61	1.63	0.33
mesothelioma cell line:ONE58	10858-111G3	20.32	7.32	0.54	0.00	0.81
migratory langerhans cells, donor1	11901-125F2	33.97	5.18	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	26.13	5.13	1.47	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	55.10	6.10	1.26	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	44.73	21.22	0.00	1.63	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.72	18.01	0.00	0.42	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	34.09	13.59	0.46	0.00	3.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.76	33.87	6.66	1.33	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	49.15	14.78	0.37	1.48	1.66
myeloma cell line:PCM6	10474-106I6	83.81	18.98	1.98	0.79	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	72.54	51.74	6.09	1.52	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.03	15.30	0.98	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	104.40	15.82	3.68	0.56	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	84.72	17.87	4.19	0.44	1.47
nasal epithelial cells, donor2	12227-129F4	70.65	14.35	4.42	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	86.73	11.27	1.15	3.45	0.23
neuroblastoma cell line:NB-1	10539-107G8	43.03	14.59	2.43	1.50	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	83.09	10.54	0.42	2.11	5.06
neuroblastoma cell line:NH-12	10555-107I6	125.79	11.93	0.19	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	82.55	4.98	0.24	1.66	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	88.22	17.26	0.95	1.74	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	64.40	8.25	0.20	1.01	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	11.44	0.64	1.91	5.09
neurofibroma cell line:Hs 53.T	10729-110A9	39.92	22.62	1.86	0.80	2.40
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	72.21	13.87	1.01	1.52	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	61.64	31.22	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.19	13.79	1.60	1.92	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	68.58	25.49	3.68	0.26	1.05
nucleus accumbens, adult, pool1	10037-101F1	12.00	3.66	0.19	0.56	0.00
occipital cortex - adult, donor10196	10172-103C1	0.00	8.24	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	16.37	3.22	0.27	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	20.02	10.19	0.36	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	6.04	5.51	0.00	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	22.31	11.59	0.43	0.86	0.00
occipital pole, adult, pool1	10036-101E9	6.86	3.55	0.16	0.16	0.08
olfactory region, adult	10195-103E6	13.56	4.39	0.38	0.19	0.19
optic nerve, donor1	10277-104E7	14.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.75	5.24	3.53	0.68	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.12	9.89	0.41	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.68	8.30	1.35	0.17	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	58.22	16.98	3.23	0.46	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	29.98	20.28	4.12	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	112.12	31.77	1.87	0.93	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	32.66	9.75	0.21	0.85	0.21
ovary, adult, pool1	10020-101D2	35.99	2.71	0.09	0.96	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.28	11.55	0.37	0.92	1.65
pancreas, adult, donor1	10049-101G4	46.09	8.47	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	75.47	27.11	4.19	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	42.42	11.58	0.68	1.19	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	55.80	4.64	0.50	0.99	0.33
paracentral gyrus, adult, pool1	10035-101E8	9.15	3.20	0.27	0.37	0.09
parietal cortex, adult, donor10258	10373-105G4	24.96	4.40	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	5.64	3.76	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	12.54	3.14	0.29	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	7.49	3.00	0.09	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	48.49	4.85	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.57	7.10	1.50	0.37	0.37
parotid gland, adult	10199-103F1	32.68	4.32	0.00	0.62	0.62
penis, adult	10200-103F2	20.95	2.15	0.54	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	88.51	5.39	0.56	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.21	5.54	1.31	0.58	0.73
pineal gland - adult, donor10196	10179-103C8	4.52	3.23	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	18.36	0.59	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	8.78	1.88	0.63	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	10.12	5.06	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	29.71	4.17	1.04	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	22.98	2.55	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	23.76	6.67	1.72	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	88.99	26.88	5.03	1.06	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.59	2.33	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	5.85	2.24	0.34	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	11.16	3.92	0.09	0.44	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	170.75	55.08	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	46.94	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	67.30	69.19	4.37	1.75	0.58
prostate cancer cell line:PC-3	10439-106E7	48.28	23.05	0.91	2.72	0.91
prostate, adult, pool1	10022-101D4	37.73	6.71	1.18	1.00	0.00
putamen, adult, donor10196	10176-103C5	16.29	2.60	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	31.37	11.76	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	17.48	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	9.66	6.04	0.00	0.48	0.00
putamen, newborn, donor10223	10365-105F5	32.24	8.25	0.00	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	67.50	18.91	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	19.47	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	61.90	22.90	1.70	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	64.20	11.18	2.90	0.41	0.00
retina, adult, pool1	10030-101E3	13.82	2.58	0.20	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	111.71	23.38	2.34	2.08	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.52	16.35	0.98	1.11	2.21
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	165.91	29.81	0.56	1.12	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	96.25	24.25	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	51.63	11.33	4.21	0.16	0.81
salivary acinar cells, donor2	11772-123I8	89.08	8.67	3.17	0.14	0.14
salivary acinar cells, donor3	11773-123I9	78.78	7.94	5.96	0.00	1.32
salivary gland, adult, pool1	10093-102C3	68.06	8.01	0.57	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.25	11.55	0.51	0.93	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.33	12.46	1.41	0.94	0.12
seminal vesicle, adult	10201-103F3	15.34	5.29	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.31	13.85	3.16	0.73	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.41	10.57	0.25	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	38.13	55.19	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	105.71	19.75	1.61	0.94	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	26.86	4.09	0.00	0.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	59.74	23.61	2.71	0.90	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	4.97	0.71	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	24.83	3.96	1.56	0.84	0.60
skeletal muscle, fetal, donor1	10066-101I3	17.09	5.03	1.01	3.02	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	34.09	11.99	0.63	0.00	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.35	25.35	4.67	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	58.63	5.36	0.00	1.58	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	104.28	60.52	7.13	10.41	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	49.28	10.55	0.49	0.49	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	129.64	17.69	0.00	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.54	6.10	1.53	0.87	0.65
small intestine, adult, pool1	10024-101D6	26.28	5.02	0.24	0.24	0.24
small intestine, fetal, donor1	10064-101I1	30.22	5.65	0.49	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	50.78	7.69	0.00	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	16.28	2.07	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	23.32	4.02	0.54	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	12.85	4.59	0.23	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	15.38	3.15	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	4.84	6.23	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	12.20	1.83	0.00	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	22.04	11.02	0.92	2.30	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	27.03	16.28	1.49	0.30	1.19
spleen, adult, pool1	10025-101D7	40.97	11.12	1.87	1.10	0.11
spleen, fetal, pool1	10044-101F8	33.13	8.02	0.72	1.35	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	91.50	18.43	4.76	1.04	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.37	2.66	0.38	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	47.18	22.36	2.45	2.45	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	131.74	37.53	5.47	0.00	5.86
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.83	18.12	2.25	0.79	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	56.76	14.83	1.27	0.85	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.15	17.77	0.42	0.42	0.85
stomach, fetal, donor1	10062-101H8	30.97	7.48	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	30.19	3.99	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.39	7.06	0.42	0.83	0.00
substantia nigra, adult, donor10258	10371-105G2	3.62	2.59	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	10.60	7.07	0.71	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	81.85	47.46	2.98	1.60	0.69
temporal lobe, adult, pool1	10031-101E4	11.27	4.83	0.42	0.51	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	21.37	2.14	0.00	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.00	4.83	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	50.27	21.30	4.54	1.40	1.40
tenocyte, donor2	11765-123I1	51.88	20.22	3.82	0.38	0.76
tenocyte, donor3	11768-123I4	63.75	33.73	5.93	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.89	16.49	1.02	2.21	2.55
teratocarcinoma cell line:NCR-G1	10798-110I6	42.54	6.78	0.46	2.31	2.00
teratocarcinoma cell line:PA-1	10807-111A6	45.10	22.94	1.86	2.48	2.63
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	42.91	25.52	1.52	1.78	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	82.44	25.72	0.76	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	95.10	22.58	2.62	0.87	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	78.49	26.38	0.33	1.63	0.98
testis, adult, pool1	10026-101D8	23.84	4.40	3.76	8.91	0.11
testis, adult, pool2	10096-102C6	37.89	11.73	7.67	8.57	0.45
thalamus - adult, donor10196	10168-103B6	2.21	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	17.97	4.06	0.31	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	6.16	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.28	2.31	0.16	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	12.08	2.30	0.00	1.73	0.58
throat, adult	10209-103G2	19.97	3.75	2.00	0.00	0.50
throat, fetal, donor1	10061-101H7	16.15	3.35	0.30	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	43.72	12.12	0.60	1.19	0.00
thymus, adult, pool1	10027-101D9	37.38	16.50	1.09	2.39	0.20
thymus, fetal, pool1	10043-101F7	27.02	6.55	0.94	1.35	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.30	23.53	1.33	1.73	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	48.47	20.95	0.98	2.65	0.28
thyroid, adult, pool1	10028-101E1	37.98	7.19	0.75	1.40	0.09
thyroid, fetal, donor1	10060-101H6	12.39	2.90	0.26	0.79	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	30.47	9.07	3.72	0.00	0.00
tongue, fetal, donor1	10059-101H5	23.25	4.73	0.79	0.00	0.79
tonsil, adult, pool1	10047-101G2	46.18	9.92	2.30	0.70	0.40
trachea, adult, pool1	10029-101E2	25.60	7.69	2.21	0.65	0.33
trachea, fetal, donor1	10058-101H4	23.08	5.00	0.77	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.22	26.92	3.54	0.35	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	35.06	7.80	2.43	3.85	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	44.34	11.28	0.78	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	53.27	22.83	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.47	7.87	0.51	0.25	0.76
umbilical cord, fetal, donor1	10057-101H3	16.69	8.35	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	53.41	4.78	0.34	0.68	0.17
uterus, fetal, donor1	10055-101H1	25.08	8.19	0.51	0.00	0.00
vagina, adult	10204-103F6	54.93	7.75	0.00	0.65	0.65
vein, adult	10191-103E2	38.80	10.30	0.88	0.44	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	106.01	26.97	4.27	0.80	0.53